RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

RBC Capital Markets maintained a positive outlook on Fiserv (NYSE:FI) shares, raising the price target to $270 from the previous $255, while keeping an Outperform rating on the stock. The adjustment ...

RBC Capital analyst Garry Sherriff maintained a Buy rating on Xero Limited (XROLF – Research Report) on February 5 and set a price target of ...

RBC Capital analyst Conor McNamara lowered the firm’s price target on Hologic (HOLX) to $85 from $88 and keeps a Sector Perform rating on the ...

Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its target price hoisted by equities researchers at Royal Bank of Canada from $11.00 to $40.00 in a report issued on Tuesday,Benzinga reports.

Royal Bank of Canada (NYSE:RY – Get Free Report) (TSE:RY) has been assigned a consensus rating of “Buy” from the seven ...

Learn more about whether RBC Bearings Incorporated or Stanley Black & Decker, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Buying $100 In RBC: If an investor had bought $100 of RBC stock 15 years ago, it would be worth $1,310.12 today based on a price of $309.55 for RBC at the time of writing. Finally -- what's the ...

ZBRA, RBC, AIT and POWL are likely to continue their momentum. SCSC stock's price momentum is backed by its efforts to enhance operational efficiency, lower debt and drive growth through acquisitions.